117 related articles for article (PubMed ID: 7510444)
1. Comparative study of hepatitis C virus antibody between hemodialysis and continuous ambulatory peritoneal dialysis patients.
Lee HY; Kang DH; Park CS; Kim KY; Kang SW; Kim HS; Choi KH; Ha SK; Han DS
Yonsei Med J; 1993 Dec; 34(4):371-80. PubMed ID: 7510444
[TBL] [Abstract][Full Text] [Related]
2. Occult HBV infection in continuous ambulatory peritoneal dialysis and hemodialysis patients.
Sav T; Gursoy S; Torun E; Sav NM; Unal A; Oymak O; Utas C
Ren Fail; 2010 Jan; 32(1):74-7. PubMed ID: 20113270
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis G virus infection in hemodialysis and continuous ambulatory peritoneal dialysis patients.
Noh H; Kang SW; Choi SH; Shin SK; Seo BJ; Lee IH; Choi KH; Han DS; Kim HS; Lee HY
Yonsei Med J; 1998 Apr; 39(2):116-21. PubMed ID: 9587251
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis.
Chan TM; Lok AS; Cheng IK
Nephrol Dial Transplant; 1991; 6(12):944-7. PubMed ID: 1724691
[TBL] [Abstract][Full Text] [Related]
5. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit.
Cendoroglo Neto M; Manzano SI; Canziani ME; Silva AE; Cirenza LF; Sesso Rde C; Ajzen H; Draibe SA
Artif Organs; 1995 Mar; 19(3):251-5. PubMed ID: 7539998
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center.
Selgas R; Martinez-Zapico R; Bajo MA; Romero JR; Munoz J; Rinon C; Miranda B; Miguel JL
Perit Dial Int; 1992; 12(1):28-30. PubMed ID: 1311962
[TBL] [Abstract][Full Text] [Related]
8. Incidence of antibodies to hepatitis C virus in patients undergoing chronic dialysis and CAPD.
Nakashima F; Sata M; Tokeshi S; Nakano H; Nakashima M; Nakashima N; Motomura K; Motomura S; Ide M; Tanikawa K
Kurume Med J; 1993; 40(4):249-53. PubMed ID: 7516454
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis.
Huang CC; Wu MS; Lin DY; Liaw YF
Perit Dial Int; 1992; 12(1):31-3. PubMed ID: 1311963
[TBL] [Abstract][Full Text] [Related]
10. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C infection in dialysis patients in Israel.
Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country.
Otedo AE; Mc'Ligeyo SO; Okoth FA; Kayima JK
S Afr Med J; 2003 May; 93(5):380-4. PubMed ID: 12830604
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors for hepatitis C virus infection in continuous ambulatory peritoneal dialysis patients.
Górriz JL; Miguel A; García-Ramón R; Pérez-Contreras J; Olivares J; Gómez-Roldán C; Alvariño J; Lanuza M
Nephrol Dial Transplant; 1996 Jun; 11(6):1109-12. PubMed ID: 8671977
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis.
Ng YY; Lee SD; Wu SC; Yang WC; Chiang SS; Huang TP
J Med Virol; 1991 Dec; 35(4):263-6. PubMed ID: 1724984
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three different tests for assessment of hepatitis C virus in dialysis patients.
Castelnovo C; Lunghi G; De Vecchi A; Grancini A; Como G; Graziani G; Scalamogna A; Ponticelli C
Perit Dial Int; 1995; 15(6):241-5. PubMed ID: 7578501
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to hepatitis C virus among hemodialysis patients in Damascus, Syria.
Othman B; Monem F
Infection; 2001 Oct; 29(5):262-5. PubMed ID: 11688903
[TBL] [Abstract][Full Text] [Related]
17. [Hepatitis C viral in patients with terminal chronic kidney failure. I. Prevalence].
González-Michaca L; Mercado A; Gamba G
Rev Invest Clin; 2000; 52(3):246-54. PubMed ID: 10953607
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against non-structural c100/3 and structural core antigen of hepatitis C virus (HCV) in hemodialysis patients.
Yoshida CF; Takahashi Y; Vanderborght BO; Rouzere CD; França MS; Takahashi C; Takamizawa A; Yoshida I; Schatzmayr HG
Rev Inst Med Trop Sao Paulo; 1993; 35(4):315-21. PubMed ID: 7509506
[TBL] [Abstract][Full Text] [Related]
19. The need for second-generation antihepatitis C virus testing in uremic patients on continuous ambulatory peritoneal dialysis.
Ng YY; Lee SD; Wu SC; Liu WT; Chia WL; Huang TP
Perit Dial Int; 1993; 13(2):132-5. PubMed ID: 7684259
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of anti-HCV positivity in patients undergoing haemodialysis or with malignant disease.
Paydas S; Aksu HS; Paydas S; Burgut R; Sagliker Y
Br J Clin Pract; 1994; 48(1):25-6. PubMed ID: 8179977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]